Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Rituximab and Cyclophosphamide Based Regimens for Treatment of Waldensterom Macroglobulemia, Lessons from Clinical Literature: A Systemic Review

Qasim Khurshid, MD, Abdul Jabbar Dar, MD, Muhammad Ali Mirza, MD, Muhaddis Ejaz Ahmad, MD, Sobia Aamir, MDFCPS, Richi Kashyap, MD, Syed Maaz Abdullah, MBBS, Muhammad Saad Farooqi, MDMBBS, Israr Khan, Arshia Akbar, MDMBBS, Waqas Khan, Muhammad Tayyeb, MD, Sundas Ali, Saad Javed, MD, Fazeel Qamar, MBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 10–11.

https://doi.org/10.1182/blood-2020-138964

Published: 2020

Journal Articles

Efficacy and Safety of Isatuximab in Relapsed Refractory Multiple Myeloma: A Systematic Review

Mydah Sajid Hashmi, MD, Ali Jaan, MD, Muhammad Ans Sharif, MBBS, Summera Aziz, Zahoor Ahmed, MD, Karun Neupane, MBBS,MD, Muhammad Salman Faisal, MD MBBS, Israr Khan, Arshia Akbar, MDMBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-136079

Published: 2020

Journal Articles

Efficacy of Daratumumab Based Regimens Compared to Standard of Care for Transplant Ineligible Newly Diagnosed Multiple Myeloma in Phase III Clinical Trials: A Meta-Analysis

Zahoor Ahmed, MD, Karun Neupane, MBBS,MD, Rabia Ashraf, MBBS, MD, Amna Khan, MBBS, MD, Moazzam Shahzad, MD, Muhammad Salman Faisal, MD MBBS, Sana Irfan Khan, MD, Abdul Rafae, MD, Arshia Akbar, MDMBBS, Ahsan Wahab, MD, Hamid Ehsan, MDMBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-137141

Published: 2020

Journal Articles

A Systematic Review of Daratumumab Based Four Drug Regimen for Newly Diagnosed Multiple Myeloma in Phase III Clinical Trials

Karun Neupane, MBBS,MD, Zahoor Ahmed, MD, Amna Khan, MBBS, MD, Rabia Ashraf, MBBS, MD, Moazzam Shahzad, MD, Shaha Nabeel, MD, Arshia Akbar, MDMBBS, Saad Javed, MD, Syed Maaz Abdullah, MBBS, Unaiza Faizan, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-138466

Published: 2020

Journal Articles

Risk of Thyroid Dysfunctions with Use of Immune Checkpoint Inhibitors: A Meta-Analysis of Randomized Controlled Trials

Muhammad Yasir Anwar, Unaiza Faizan, MD, Muhammad Khawar Sana, MD, Muhammad Ans Sharif, MBBS, Ali Anjum, MD, Hafsa Tahir Chaudry, MBBS, Sara Ashraf, MD, Muhammad Ashar Ali, MD, Arshia Akbar, MDMBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 14.

https://doi.org/10.1182/blood-2020-136972

Published: 2020

Journal Articles

Emerging Role of Adoptive T Cell Therapy for EBV Induced Nasopharyngeal Carcinoma (NPC) - a Systematic Review

Muhammad Saad Farooqi, MDMBBS, Unaiza Faizan, MD, Saad Ur Rahman, MBBS, Hassaan Imtiaz, MD, Muhammed Hamza Arshad, MD, Arafat Ali Farooqui, MD, Zahoor Ahmed, MD, Muhammad Ali Aziz, MD, Ali Jaan, MD, Ali Shahbaz Baloch, MD, Naurez Qasim, MD, Arshia Akbar, MDMBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-137139

Published: 2020

Journal Articles

CD-19 Specific CAR-T Cell Therapy in Relapsed/Refractory ALL in Pediatrics and Young Adults; Safety and Efficacy Outcomes: A Systematic Review and Meta-Analysis

Sobia Aamir, MDFCPS, Muhammad Ashar Ali, MD, Sana Irfan Khan, MD, Abdul Jabbar Dar, MD, Farhan Khalid, MBBS, Muhammad Yasir Anwar, Muhammad Tayyeb, MD, Anam Khan, Atif Irfan Khan, MD, Syeda Sabeeka Batool, MBBS, MD, Arshia Akbar, MDMBBS, Seemal Iftikhar, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 10–11.

https://doi.org/10.1182/blood-2020-134059

Published: 2020

Journal Articles

A Systemic Review on Efficacy of Ibrutinib-Based Regimens for the Treatment of Waldenstrom Macroglobulinemia

Qasim Khurshid, MD, Abdul Jabbar Dar, MD, Muhammad Ali Mirza, MD, Muhaddis Ejaz Ahmad, MD, Ali Jaan, MD, Sobia Aamir, MDFCPS, Syed Maaz Abdullah, MBBS, Richi Kashyap, MD, Israr Khan, Waqas Khan, Sundas Ali, Arshia Akbar, MDMBBS, Saad Javed, MD, Fazeel Qamar, MBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-138765

Published: 2020

Journal Articles

A Systematic Review and Meta-Analysis of Luspatercept for Anemia Treatment in Low Risk Myelodysplastic Syndrome with Ring Sideroblast Subtype in Phase II and Phase III Clinical Trials

Arshia Akbar, MDMBBS, Waqas Khan, Zunairah Shah, MBBS, Muhammad Yasir Anwar, Muhammad Ali Aziz, MD, Zahoor Ahmed, MD, Muhammad Saad Farooqi, MDMBBS, Ali Shahbaz Baloch, MD, Mydah Sajid Hashmi, MD, Qasim Khurshid, MD, Abdul Jabbar Dar, MD, Saman Bahram, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-137152

Published: 2020

Journal Articles

Reduced-Intensity Versus Myeloablative Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials & Cohort Studies

Arshia Akbar, MDMBBS, Zunairah Shah, MBBS, Muhammad Ali Aziz, MD, Muhammad Yasir Anwar, Saman Bahram, Waqas Khan, Zahoor Ahmed, MD, Qasim Khurshid, MD, Abdul Jabbar Dar, MD, Anum Javaid, MD, Neelam Asghar, Harsh Patel, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-138771

Published: 2020

NARROW

Rituximab and Cyclophosphamide Based Regimens for Treatment of Waldensterom Macroglobulemia, Lessons from Clinical Literature: A Systemic Review

Efficacy and Safety of Isatuximab in Relapsed Refractory Multiple Myeloma: A Systematic Review

Efficacy of Daratumumab Based Regimens Compared to Standard of Care for Transplant Ineligible Newly Diagnosed Multiple Myeloma in Phase III Clinical Trials: A Meta-Analysis

A Systematic Review of Daratumumab Based Four Drug Regimen for Newly Diagnosed Multiple Myeloma in Phase III Clinical Trials

Risk of Thyroid Dysfunctions with Use of Immune Checkpoint Inhibitors: A Meta-Analysis of Randomized Controlled Trials

Emerging Role of Adoptive T Cell Therapy for EBV Induced Nasopharyngeal Carcinoma (NPC) - a Systematic Review

CD-19 Specific CAR-T Cell Therapy in Relapsed/Refractory ALL in Pediatrics and Young Adults; Safety and Efficacy Outcomes: A Systematic Review and Meta-Analysis

A Systemic Review on Efficacy of Ibrutinib-Based Regimens for the Treatment of Waldenstrom Macroglobulinemia

A Systematic Review and Meta-Analysis of Luspatercept for Anemia Treatment in Low Risk Myelodysplastic Syndrome with Ring Sideroblast Subtype in Phase II and Phase III Clinical Trials

Reduced-Intensity Versus Myeloablative Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials & Cohort Studies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only